Neonatal Health: The Impact of Group B Streptococcus Screening, NAAT-based Detection, and Prophylactic Interventions

Neonatal Health: The Impact of Group B Streptococcus Screening, NAAT-based Detection, and Prophylactic Interventions

During this program, Group B Streptococcus (GBS, Streptococcus agalactiae), a public health concern and a cause of serious newborn morbidity and mortality1, will be discussed by Dr. Gregory J. Berry. Objectives include:

  • Describe GBS including the causes, risks, and symptoms of the infection
  • State the guidelines for GBS screening from the American Society for Microbiology (ASM) and the American College of Obstetricians and Gynecologists (ACOG)
  • Compare the diagnostic testing methods of culture and nucleic acid amplification testing (NAAT) for GBS
  • Outline options for the prevention and management of GBS early on-set disease (EOD)
  • Recognize the success of GBS screening strategies and their impact on EOD rates

 

  1. Symptoms of Group B Strep Disease. Published January 3, 2024. Accessed January 15, 2025. https://www.cdc.gov/group-b-strep/symptoms/index.html